No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial

Author:

Naficy Abdi1ORCID,Kuxhausen Adrienne1ORCID,Seifert Harry1ORCID,Hastie Andrew1ORCID,Leav Brett2ORCID,Miller Jacqueline2ORCID,Anteyi Kate2ORCID,Mwakingwe-Omari Agnes1ORCID

Affiliation:

1. GSK, Rockville, MD, USA

2. Moderna, Inc, Cambridge, MA, USA

Funder

GlaxoSmithKline Biologicals

Publisher

Informa UK Limited

Reference43 articles.

1. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

2. Influenza: Can we cope better with the unpredictable?

3. Covid-19: virology, variants, and vaccines

4. Who and when to vaccinate against influenza

5. VRBPAC. Vaccines and Related Biological Products Advisory Committee Meeting. Selection of strain(s) to be included in the periodic updated COVID-19 vaccines for the 2023–2024 vaccination campaign; 2023 Jun 15 [accessed 2023 Jun 21]. https://www.fda.gov/media/169538/download.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3